CytoDel announces successful intra-neuronal antibody delivery without a viral vector
Researchers at CytoDel developed a precision biotherapeutic that can enter neurons and protect SNARE proteins by inhibiting botulinum neurotoxin's catalytic activity. This non-viral delivery method has potential for treating multiple neurological diseases, including synaptopathies.